• Bayer priced USD 5 billion of new fixed-rate bonds in five tranches with maturities spanning 5 to 30 years.
• Deal sized at USD 1 billion due 2031, USD 750 million due 2033, USD 1.5 billion due 2036.
• Longer tranches include USD 500 million due 2046, USD 1.25 billion due 2056; coupons range 5.125% to 6.375%.
• Expected ratings: Baa2 at Moody’s, BBB at S&P, BBB at Fitch; issuance via Bayer US Finance, guaranteed by Bayer.
• Net proceeds earmarked for general corporate purposes; closing targeted for July 20, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein.